Toronto - About 20 percent of critically ill hospital patients - including many with skin and skin structure infections - treated with vancomycin are now at risk of developing nephrotoxicity, a new study shows.
Insights into Bimekizumab 2-Year Data for PsA, nr-asSpA, and AS
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Deep Histological Margins Do Not Increase cSCC Recurrence Risk if Tumor is Fully Excised
The Cutaneous Connection: Enhancing Vitiligo Care With Nanette Silverberg, MD
Latex Gloves and the Americans With Disabilities Act
Live From Chicago: Bringing Sun Protection Awareness to Communities